Tumor-Suppressive Functions of the Aryl Hydrocarbon Receptor (AhR) and AhR as a Therapeutic Target in Cancer

por Elson, Daniel J., Kolluri, Siva K.
Publicado 2023

Mesenchymal Stem Cells as Vectors for Lung Cancer Therapy

por Kolluri, Krishna K., Laurent, Geoff J., Janes, Sam M.
Publicado 2013

TRAIL delivery by MSC-derived extracellular vesicles is an effective anticancer therapy

por Yuan, ZhengQiang, Kolluri, Krishna K., Gowers, Kate H. C., Janes, Sam M.
Publicado 2017

The aryl hydrocarbon receptor mediates raloxifene-induced apoptosis in estrogen receptor-negative hepatoma and breast cancer cells

por O'Donnell, E F, Koch, D C, Bisson, W H, Jang, H S, Kolluri, S K
Publicado 2014

The Zebrafish Xenograft Models for Investigating Cancer and Cancer Therapeutics

por Gamble, John T., Elson, Daniel J., Greenwood, Juliet A., Tanguay, Robyn L., Kolluri, Siva K.
Publicado 2021

Mesenchymal stromal cell delivery of full-length tumor necrosis factor–related apoptosis-inducing ligand is superior to soluble type for cancer therapy

por Yuan, ZhengQiang, Kolluri, Krishna K., Sage, Elizabeth K., Gowers, Kate H.C., Janes, Sam M.
Publicado 2015

Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapy

por Yuan, Zhengqiang, Lourenco, Sofia Da Silva, Sage, Elizabeth K., Kolluri, Krishna K., Lowdell, Mark W., Janes, Sam M.
Publicado 2016

A Structural Switch between Agonist and Antagonist Bound Conformations for a Ligand-Optimized Model of the Human Aryl Hydrocarbon Receptor Ligand Binding Domain

por Perkins, Arden, Phillips, Jessica L., Kerkvliet, Nancy I., Tanguay, Robert L., Perdew, Gary H., Kolluri, Siva K., Bisson, William H.
Publicado 2014

Non-Invasive Longitudinal Bioluminescence Imaging of Human Mesoangioblasts in Bioengineered Esophagi

por Crowley, Claire, Butler, Colin R., Camilli, Carlotta, Hynds, Robert E., Kolluri, Krishna K., Janes, Sam M., De Coppi, Paolo, Urbani, Luca
Publicado 2019

Leveraging a High-Throughput Screening Method to Identify Mechanisms of Individual Susceptibility Differences in a Genetically Diverse Zebrafish Model

por Wallis, Dylan J., La Du, Jane, Thunga, Preethi, Elson, Daniel, Truong, Lisa, Kolluri, Siva K., Tanguay, Robyn L., Reif, David M.
Publicado 2022

Dietary Indole-3-Carbinol Activates AhR in the Gut, Alters Th17-Microbe Interactions, and Exacerbates Insulitis in NOD Mice

por Kahalehili, Heather M., Newman, Nolan K., Pennington, Jamie M., Kolluri, Siva K., Kerkvliet, Nancy I., Shulzhenko, Natalia, Morgun, Andrey, Ehrlich, Allison K.
Publicado 2021

CADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity

por Vallath, Sabari, Sage, Elizabeth K., Kolluri, Krishna K., Lourenco, Sofia N., Teixeira, Vitor S., Chimalapati, Suneeta, George, P. Jeremy, Janes, Sam M., Giangreco, Adam
Publicado 2016

Delineation of hypoxia-induced proteome shifts in osteosarcoma cells with different metastatic propensities

por Song, Zifeng, Pearce, Martin C., Jiang, Yuan, Yang, Liping, Goodall, Cheri, Miranda, Cristobal L., Milovancev, Milan, Bracha, Shay, Kolluri, Siva K., Maier, Claudia S.
Publicado 2020

BAP1 and YY1 regulate expression of death receptors in malignant pleural mesothelioma

por Ishii, Yuki, Kolluri, Krishna K., Pennycuick, Adam, Zhang, Xidan, Nigro, Ersilia, Alrifai, Doraid, Borg, Elaine, Falzon, Mary, Shah, Khalid, Kumar, Neelam, Janes, Sam M.
Publicado 2021

Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma

por Sage, Elizabeth K, Kolluri, Krishna K, McNulty, Katrina, Lourenco, Sofia Da Silva, Kalber, Tammy L, Ordidge, Katherine L, Davies, Derek, Gary Lee, Y C, Giangreco, Adam, Janes, Sam M
Publicado 2014

Lung delivery of MSCs expressing anti-cancer protein TRAIL visualised with (89)Zr-oxine PET-CT

por Patrick, P. Stephen, Kolluri, Krishna K., Zaw Thin, May, Edwards, Adam, Sage, Elizabeth K., Sanderson, Tom, Weil, Benjamin D., Dickson, John C., Lythgoe, Mark F., Lowdell, Mark, Janes, Sam M., Kalber, Tammy L.
Publicado 2020